These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19961440)

  • 41. Preoperative levosimendan for right ventricular dysfunction before heart valve replacement surgery.
    Guerrero Orriach JL; Navarro Arce I; Iglesias P; Galán Ortega M; Rubio Navarro M; Cruz Mañas J
    Rev Esp Cardiol (Engl Ed); 2013 Dec; 66(12):999-1000. PubMed ID: 24774116
    [No Abstract]   [Full Text] [Related]  

  • 42. Levosimendan: a new dual-action drug in the treatment of acute heart failure.
    Mebazaa A; Erhardt L
    Int J Clin Pract; 2003 Jun; 57(5):410-6. PubMed ID: 12846347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peripartum cardiomyopathy: a new successful setting for levosimendan.
    Benezet-Mazuecos J; de la Hera J
    Int J Cardiol; 2008 Jan; 123(3):346-7. PubMed ID: 17324479
    [No Abstract]   [Full Text] [Related]  

  • 44. Patients with advanced heart failure and the effects of levosimendan.
    Song ZZ; Ma J
    Am J Cardiol; 2007 Aug; 100(4):742; author reply 742-3. PubMed ID: 17697841
    [No Abstract]   [Full Text] [Related]  

  • 45. Levosimendan--an inoprotective drug or much ado about nothing?
    Lehmann A; Radke J; Sack FU
    Crit Care Med; 2011 Oct; 39(10):2365-6. PubMed ID: 21926495
    [No Abstract]   [Full Text] [Related]  

  • 46. Preoperative levosimendan in ischemic mitral valve repair.
    Sharma P; Malhotra A; Gandhi S; Garg P; Bishnoi A; Gandhi H
    Asian Cardiovasc Thorac Ann; 2014 Jun; 22(5):539-45. PubMed ID: 24867027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A dose-response study of levosimendan in a porcine model of acute ischaemic heart failure.
    Kolseth SM; Wahba A; Kirkeby-Garstad I; Aro S; Nordgaard H; Høydal M; Rognmo Ø; Nordhaug D
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1377-83. PubMed ID: 22219475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
    Cleland JG; Nikitin N; McGowan J
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of temperature on the positive inotropic effect of levosimendan, dobutamine and milrinone.
    Rieg AD; Schroth SC; Grottke O; Hein M; Ackermann D; Rossaint R; Schälte G
    Eur J Anaesthesiol; 2009 Nov; 26(11):946-53. PubMed ID: 19687740
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levosimendan for the treatment of acute heart failure syndromes: time to identify subpopulations of responding patients.
    Parissis JT; Farmakis D; Bistola V; Adamopoulos S; Kremastinos DT
    Am J Cardiol; 2007 Jan; 99(1):146-7. PubMed ID: 17196480
    [No Abstract]   [Full Text] [Related]  

  • 51. Levosimendan cardioprotection in acutely beta-1 adrenergic receptor blocked open chest pigs.
    Metzsch C; Linnér R; Steen S; Liao Q; Algotsson L
    Acta Anaesthesiol Scand; 2010 Jan; 54(1):103-10. PubMed ID: 19681782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levosimendan. A promising future drug for refractory cardiac failure in children?
    Kushwah S; Kumar A; Sahana KS
    Indian Heart J; 2016 Apr; 68 Suppl 1(Suppl 1):S57-60. PubMed ID: 27056655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta blocker therapy, decompensated heart failure, and inotropic interactions: current perspectives.
    Zafrir B; Amir O
    Isr Med Assoc J; 2012 Mar; 14(3):184-9. PubMed ID: 22675861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute effects of levosimendan on mitral regurgitation and diastolic function in patients with advanced chronic heart failure.
    Branzi G; Malfatto G; Villani A; Ciambellotti F; Revera M; Giglio A; Rosa FD; Facchini M; Parati G
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):662-8. PubMed ID: 20613551
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early levosimendan administration may improve outcome in patients with subarachnoid hemorrhage complicated by acute heart failure.
    Papanikolaou J; Tsolaki V; Makris D; Zakynthinos E
    Int J Cardiol; 2014 Oct; 176(3):1435-7. PubMed ID: 25147072
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of baseline characteristics on mortality in the SURVIVE trial on the effect of levosimendan vs dobutamine in acute heart failure: Sub-analysis of the Finnish patients.
    Kivikko M; Pollesello P; Tarvasmäki T; Sarapohja T; Nieminen MS; Harjola VP
    Int J Cardiol; 2016 Jul; 215():26-31. PubMed ID: 27107540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ST-segment elevation during levosimendan infusion.
    Barillà F; Giordano F; Jacomelli I; Pellicano M; Dominici T
    J Cardiovasc Med (Hagerstown); 2012 Jul; 13(7):454-6. PubMed ID: 22673026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prolonged lowering effect of levosimendan on brain natriuretic peptide levels in patients with decompansated heart failure: clinical implications.
    Celik T; Iyisoy A; Yuksel UC; Kardesoglu E
    Int J Cardiol; 2008 Aug; 128(1):97-9; authr reply 100-2. PubMed ID: 18501448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Usefulness of Levosimendan in patients with ventricular dysfunction before surgery].
    Bauk L; López OF; Miranda GS; Abdala GG; Mora EL; de la Reguera GF
    Arch Cardiol Mex; 2004; 74(4):295-300. PubMed ID: 15709507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intracoronary infusion of levosimendan to treat postpericardiotomy heart failure.
    Caimmi PP; Grossini E; Molinari C; Vacca G; Teodori G
    Ann Thorac Surg; 2006 Nov; 82(5):e33-4. PubMed ID: 17062205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.